ZA948060B - Galanthamide derivatives,a process for their preparation and their use as medicaments - Google Patents
Galanthamide derivatives,a process for their preparation and their use as medicamentsInfo
- Publication number
- ZA948060B ZA948060B ZA948060A ZA948060A ZA948060B ZA 948060 B ZA948060 B ZA 948060B ZA 948060 A ZA948060 A ZA 948060A ZA 948060 A ZA948060 A ZA 948060A ZA 948060 B ZA948060 B ZA 948060B
- Authority
- ZA
- South Africa
- Prior art keywords
- galanthamide
- medicaments
- derivatives
- preparation
- alkylaminocarbonyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/137,443 US6323196B1 (en) | 1993-10-15 | 1993-10-15 | Galanthamine derivatives as acetylcholinesterase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA948060B true ZA948060B (en) | 1995-06-09 |
Family
ID=22477457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA948060A ZA948060B (en) | 1993-10-15 | 1994-10-14 | Galanthamide derivatives,a process for their preparation and their use as medicaments |
Country Status (24)
Country | Link |
---|---|
US (1) | US6323196B1 (de) |
EP (2) | EP0648771B1 (de) |
JP (1) | JP2718637B2 (de) |
KR (1) | KR100189043B1 (de) |
CN (1) | CN1039011C (de) |
AT (1) | ATE201687T1 (de) |
AU (1) | AU679560B2 (de) |
CA (1) | CA2118171C (de) |
CZ (1) | CZ283561B6 (de) |
DE (1) | DE69427332T2 (de) |
DK (1) | DK0648771T3 (de) |
EG (1) | EG20747A (de) |
ES (1) | ES2158876T3 (de) |
FI (1) | FI108724B (de) |
GR (1) | GR3036068T3 (de) |
IL (1) | IL111273A (de) |
NO (1) | NO307463B1 (de) |
NZ (1) | NZ264681A (de) |
PL (1) | PL177754B1 (de) |
PT (1) | PT648771E (de) |
RO (1) | RO114132B1 (de) |
RU (1) | RU2113438C1 (de) |
TW (1) | TW375615B (de) |
ZA (1) | ZA948060B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403803B (de) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
AU1738800A (en) | 1998-11-23 | 2000-06-13 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
BR9916835A (pt) | 1998-12-24 | 2001-09-25 | Janssen Pharmaceutica Nv | Composição de galantamina de liberação controlada |
EP1237524A4 (de) * | 1999-12-10 | 2004-06-30 | Bonnie M Davis | Analoga des galanthamins und lycoramins als modulatoren von nikotinrezeptoren |
SK285909B6 (sk) | 2000-03-31 | 2007-10-04 | Sanochemia Pharmazeutika Aktiengesellschaft | Deriváty a analógy galantamínu, spôsob ich výroby, ich použitie na výrobu liečiva, spôsob výroby tohto liečiva a spôsob separácie (+) a (-) izomérov racemických derivátov a analógov galantamínu |
US20030162770A1 (en) * | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
US20040142970A1 (en) * | 2002-11-01 | 2004-07-22 | Kathryn Chung | Treatment of hyperkinetic movement disorder with donepezil |
US20050048543A1 (en) * | 2003-07-11 | 2005-03-03 | Jeroen Aerssens | CHRNA2 genetic markers associated with galantamine response |
US20050260613A1 (en) * | 2003-10-28 | 2005-11-24 | Genaissance Pharmaceuticals | LRPAP1 genetic markers associated with galantamine |
US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
US7250258B2 (en) * | 2003-12-15 | 2007-07-31 | Pgxhealth Llc | CDK5 genetic markers associated with galantamine response |
CA2552114A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
CA2551946A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galantamine |
US20080045500A1 (en) * | 2004-07-01 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Nerve Regeneration Stimulator |
EP1895995A2 (de) * | 2005-05-13 | 2008-03-12 | Alza Corporation | Mehrschichtige transdermale systeme zur galantamine abgabe |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
EP1777222A1 (de) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Cholinesterase Inhibitoren mit erhöter Blut Hirn Schranke Permeabilität zur Behandlung von kognitiven Störungen |
WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
KR100786371B1 (ko) * | 2006-12-07 | 2007-12-17 | 한국화학연구원 | 갈란타민의 제조방법 |
EP2137192B8 (de) | 2008-04-14 | 2014-06-11 | Neurodyn Life Sciences Inc. | Galantaminderivate als Prodrug-Verbindungen zur Behandlung humaner Hirnerkrankungen |
CA2768668A1 (en) * | 2009-07-23 | 2011-01-27 | Shire Llc | Galantamine amino acid and peptide prodrugs and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL122665B1 (en) | 1978-11-21 | 1982-08-31 | Edinen Zentar Chim | Process for preparing novel dienones of narvedine type and their derivatives |
US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
EP0363415B1 (de) * | 1987-05-04 | 2008-10-15 | Davis, Bonnie | Mittel zur behandlung der alzheimer-krankheit |
NL8800350A (nl) | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
DK0584185T3 (da) | 1991-05-14 | 2000-02-07 | Ernir Snorrason | Behandling af træthedssyndrom med cholinesteraseinhibitorer |
US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
US5231093A (en) * | 1991-10-01 | 1993-07-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
-
1993
- 1993-10-15 US US08/137,443 patent/US6323196B1/en not_active Expired - Lifetime
-
1994
- 1994-10-10 EP EP94115960A patent/EP0648771B1/de not_active Expired - Lifetime
- 1994-10-10 ES ES94115960T patent/ES2158876T3/es not_active Expired - Lifetime
- 1994-10-10 EP EP00107569A patent/EP1020469A3/de not_active Withdrawn
- 1994-10-10 PT PT94115960T patent/PT648771E/pt unknown
- 1994-10-10 DK DK94115960T patent/DK0648771T3/da active
- 1994-10-10 AT AT94115960T patent/ATE201687T1/de active
- 1994-10-10 DE DE69427332T patent/DE69427332T2/de not_active Expired - Lifetime
- 1994-10-12 EG EG63794A patent/EG20747A/xx active
- 1994-10-13 IL IL111273A patent/IL111273A/en not_active IP Right Cessation
- 1994-10-13 RU RU94036761A patent/RU2113438C1/ru active
- 1994-10-13 FI FI944822A patent/FI108724B/fi not_active IP Right Cessation
- 1994-10-13 NZ NZ264681A patent/NZ264681A/en not_active IP Right Cessation
- 1994-10-14 RO RO94-01668A patent/RO114132B1/ro unknown
- 1994-10-14 CZ CZ942547A patent/CZ283561B6/cs not_active IP Right Cessation
- 1994-10-14 CA CA002118171A patent/CA2118171C/en not_active Expired - Lifetime
- 1994-10-14 CN CN94117061A patent/CN1039011C/zh not_active Expired - Lifetime
- 1994-10-14 AU AU75812/94A patent/AU679560B2/en not_active Expired
- 1994-10-14 TW TW083109528A patent/TW375615B/zh not_active IP Right Cessation
- 1994-10-14 KR KR1019940026304A patent/KR100189043B1/ko active IP Right Grant
- 1994-10-14 PL PL94305455A patent/PL177754B1/pl unknown
- 1994-10-14 ZA ZA948060A patent/ZA948060B/xx unknown
- 1994-10-14 NO NO943894A patent/NO307463B1/no not_active IP Right Cessation
- 1994-10-17 JP JP6250776A patent/JP2718637B2/ja not_active Expired - Fee Related
-
2001
- 2001-06-19 GR GR20010400911T patent/GR3036068T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA948060B (en) | Galanthamide derivatives,a process for their preparation and their use as medicaments | |
AU1433588A (en) | 1-phenyl-3-naphthalenyloxypropanamines | |
AU7581494A (en) | Galanthamine derivatives, a process for their preparation and their use as medicaments | |
AU591640B2 (en) | Quinolonecarboxylic acid derivatives | |
AU2722095A (en) | Novel pyrrolocarbazoles | |
AU636351B2 (en) | N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments | |
BG51251A3 (en) | Method for the preparetion of tetrahydroimidazo /1,4/-benzodiazepine (?)-2-ketons | |
EP1034783A4 (de) | Amidederivaten | |
DE3477380D1 (en) | Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions | |
EP0555479A4 (de) | ||
HU895612D0 (en) | Process for producing pyrrolidine derivatives | |
AU2014188A (en) | Naphthothiazepine derivatives and preparation thereof | |
GR3002688T3 (en) | Thiadiazolylacetamide derivatives, process for the preparation thereof and their use | |
GR3030952T3 (en) | Salmycins, a process for their preparation and their use as a pharmaceutical. | |
HK34095A (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases |